Merck says will not seek approval of cholesterol treatment
October 11, 2017 at 17:14 PM EDT
Oct 11 (Reuters) - Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile of the treatment does not support regulatory filings.
